Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Alexion to commence phase Ib pilot study of 5G1.1 in pemphigoid patients

April 7, 2000

AstraZeneca develops new class of MMP inhibitors with selectivity for MMP-13, MMP-9

April 7, 2000

British Biotech designs more MMP-inhibitory hydroxamic acid derivatives

April 6, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

Scios compounds useful for conditions characterized by excess p38alpha or TGF-beta activity

April 5, 2000

Aventis launches Arava in Canada for treatment of rheumatoid arthritis

April 5, 2000

Japan Energy describes preparation and use of cPLA2 inhibitors

April 4, 2000

COX-2-inhibitory indole compounds synthesized by Pfizer

April 3, 2000

Diarylbenzopyran derivatives designed at Pacific for inflammation, pain and fever

March 31, 2000

Pfizer claims NSAIDs linked to NO-releasing moiety associated with reduced GI toxicity

March 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...